Towards low-volume production and personalised medicine

subscribe to our newsletter

3D printing is making a name for itself in medicine manufacturing. While it’s hard to foresee the wholesale replacement of current tablet manufacturing processes, 3D printing is expected to find a place in certain niche medications and in personalised tablets.

For so-called orphan drugs, the inherent versatility of 3D printing is particularly appealing. Rather than the current situation of pharmaceutical companies needing to maintain expensive specialist infrastructure to manufacture medicines of which low numbers are sold, it is theoretically possible to print many different types of tablets by simply changing the powder used, or even by just changing the ‘ink cartridges’ in commercially available 3D printers.

This ink cartridge concept also offers the possibility of decentralising tablet manufacture in certain circumstances. It also opens up the possibility of using 3D printing in personalised medicine – to produce a tablet designed to meet the needs of a single patient, the drug loading, combination of drugs and the release profile of the formulation.

Topics of the conference

  • Faster pre-clinical evaluation of new drugs
  • New formulations for improved drug delivery
  • Patient-centric design / personalised medicine
  • Local manufacture / Simplified logistics
  • Reduced wastage
  • Regulation / Certification
  • Safety / Quality control

This conference (1st edition in 2017), which is part of the 3D Medical Printing Series, will bring together the international Pharmaceutical community to showcase the work of researchers and industry in the 3D Pharmaceutical Printing field and its applications, with a view to fostering closer ties and collaborations. The overall goal of this conference is to address both the technologies and the applications — from early technology development to downstream applications.

Accreditation
The 3D Pharma Printing Conference 4-2-2021 has been accredited by The Dutch Association for Technical Medicine with 4 (Continuing Medical Education) CME credits.

Early-stage and Start-Up Companies will find this conference an excellent source of networking opportunities with key opinion leaders participating and speaking.

The 3D Pharma Printing Conference is part of the 3D Medical Printing Series, which encompasses four online conferences during two weeks:

3D Bioprinting is the utilization of 3D printing and 3D printing–like techniques to combine cells, growth factors, and biomaterials to fabricate biomedical parts that maximally imitate natural tissue characteristics. 3D Bioprinting holds much promise in advancing medicine as tool to replicate cellular complexity of tissue environment, ex vivo for drug screening and as a means of engineering well-defined functional tissue units for transplantation (scaffolds, which can be used to regenerate joints and ligaments).
3D printing is making a name for itself in medicine manufacturing. While it’s hard to foresee the wholesale replacement of current tablet manufacturing processes, 3D printing is expected to find a place in certain niche medications and in personalised tablets. For so-called orphan drugs, the inherent versatility of 3D printing is particularly appealing. Rather than the current situation of pharmaceutical companies needing to maintain expensive specialist infrastructure to manufacture medicines of which low numbers are sold, it is theoretically possible to print many different types of tablets by simply changing the powder used, or even by just changing the ‘ink cartridges’ in commercially available 3D printers.
From medical implants to medical devices, The 3D MedTech printing market can be categorized as medical implants, surgical guides, surgical instruments, medical devices and hearing aids. The medical implant segment is expected to grow at the fastest rate among all applications in the coming years.
3D printing is taking its place for dental, orthodontic, stomatological and maxillofacial applications. 3D Dental Printing is part of the overall Digital dentistry which refers to the use of dental technologies or devices that incorporates digital or computer-controlled components to carry out dental procedures rather than using mechanical or electrical tools.

Target groups
Pharmaceutical, biopharmaceutical and Biotech professionals | Regulators | Compliance Officers | Pharmacists | Laboratory Personnel | Consultants | Contractors/Subcontractors | 3D Printing suppliers | anyone responsible for medicine/drug: Development | Manufacturing | Preclinical | Quality Assurance | Quality Control | Operations | Surgeons | Medical Engineers | Research Institutes | Medical professionals | Radiologists | Cardiologists | Oncologists | Orthopedists | Nurses | Bioengineers | Biomedical Engineers | Medical Scientists | Clinical Data Scientists |